retatrutide study sign up A of (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) Retatrutide Shows Significant Improvements in

Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z et al

Possible mild side effects may include: Temporary redness, swelling, or irritation at the injection site Mild water retention Occasional headaches or dizziness Temporary changes in energy levels or sex drive Most side effects are short-lived and improve as the body adapts

, ,

(2006) 291:E46875

A hiny tnetei lehetnek a fradkonysg, izomgyengesg, koncentrcizavar vagy cskkent llkpessg

Common Medications Semaglutide (Wegovy and Ozempic for SQ injections, Rybelsus for PO) Liraglutide (Saxenda and Victoza for SQ injections) Tirzepatide (Mounjaro) Mechanism of Action GLP-1 is an incretin hormone produced in the small intestine, and it binds the GLP-1 receptor, thus enhancing the effects of endogenous GLP-1